Besides PD-L1 expression, stromal tumor-infiltrating lymphocyte (sTIL) and CD8+ T cell levels, deconvolution algorithms and specific immune-related gene signatures were used to dissect the effect on the various T cell populations and other elements of the cancer-immunity cycle. The gene discussed is CD274; the disease is neoplasm.